Country intelligence
Deals, market moves, science and policy across the platform tagged to Lithuania.
A 2019 framework that remains slow to implement, with no patients treated and cultivation prohibited.
The framework allows companies to obtain manufacturing, wholesale, trade and retail licences through the State Medicines Control Agency, but cultivation is prohibited and implementation has stalled. Patients with cancer, MS, epilepsy and AIDS are technically eligible.
Nothing tagged to Lithuania yet. Tag deals, studies or articles with this country to see them here and on the map.
